Stock Taper
OPPORTUNITY RADAR SCREENER COMPARE ANY 2 STOCKS
EXCHANGE TRADED FUND

BBC

Virtus Biotech Clinical Trials ETF
$44.15 ▲ 2.08%
+$0.90 TODAY

FUND FACTS

Manager Virtus
Assets $41.18M
Expense ratio 0.65%
Inception Dec 16, 2014
Asset class Sector Equity
Holdings 130
Volume 5.32K
Avg volume 21.46K

ABOUT THIS FUND

This exchange-traded fund (ETF) endeavors to match the capital appreciation and income generation of the LifeSci Biotechnology Clinical Trials Index, disregarding fees and expenses. The underlying index focuses on tracking the financial progress of a carefully chosen group of biotechnology firms engaged in clinical trials. It is important to note that, as of February 27, the fund's official name transitioned from Virtus LifeSci Biotech Clinical Trials ETF to Virtus Biotech Clinical Trials ETF.

PRICE

$44.15 ▲ UP 2.08% (+$0.90)
$43.00$43.50$44.00$44.509:30 AM10:34 AM11:38 AM12:42 PM1:45 PM2:49 PM3:53 PM44.15

HOLDINGS

TOP 20 OF 130 · 24.71% OF THE FUND
RANK STOCK WEIGHT SHARES VALUE
01 KOD Kodiak Sciences Inc. 2.09% 9.32K $860.33K
02 ABCL AbCellera Biologics Inc. 1.93% 60.56K $796.36K
03 XNCR Xencor, Inc. 1.52% 25.74K $626.95K
04 AMLX Amylyx Pharmaceuticals, Inc. 1.48% 21.75K $609.87K
05 TRAX First Tracks Biotherapeutics Inc 1.37% 17.99K $564.67K
06 MBX MBX Biosciences, Inc. Common Stock 1.24% 8.94K $508.64K
07 REPL Replimune Group, Inc. 1.15% 35.74K $473.5K
08 RXRX Recursion Pharmaceuticals, Inc. 1.13% 100.74K $466.43K
09 SLS SELLAS Life Sciences Group, Inc. 1.12% 40.53K $459.59K
10 ORIC ORIC Pharmaceuticals, Inc. 1.12% 38.37K $459.7K
11 DFTX Definium Therapeutics, Inc. 1.11% 12.82K $456.72K
12 FDMT 4D Molecular Therapeutics, Inc. 1.10% 35.94K $451.38K
13 PCVX Vaxcyte, Inc. 1.08% 6.69K $445.96K
14 ANL Adlai Nortye Ltd. 1.08% 30.75K $444.63K
15 ZBIO Zenas BioPharma, Inc. 1.05% 16.03K $431.77K
16 VIR Vir Biotechnology, Inc. 1.04% 36.86K $427.53K
17 SGP SpyGlass Pharma, Inc. Common Stock 1.04% 17.21K $426.44K
18 MNPR Monopar Therapeutics Inc. 1.03% 5.31K $422.44K
19 NRIX Nurix Therapeutics, Inc. 1.03% 18.72K $423.12K
20 RVMD Revolution Medicines, Inc. 1.00% 2.06K $412.13K

SECTOR HOLDINGS

TECHNOLOGY IS 100.00% OF THE FUND
Healthcare 100.00%

BY REGION

UNITED STATES IS 89.74% OF THE FUND
United States 89.74%
Canada 2.43%
Netherlands 2.01%
Ireland 1.56%
United Kingdom 1.46%
China 1.05%
Switzerland 1.04%
Germany 0.61%
— Other 0.11%